Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 10, Issue 4, Pages 334-342Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2006.06.028
Keywords
-
Categories
Funding
- NCI NIH HHS [P50 CA94056] Funding Source: Medline
Ask authors/readers for more resources
Recent advances in non-invasive molecular imaging provide exciting opportunities for discovery, validation and development of novel therapeutics. As the arsenal of detection devices and strategies, injectable probes, genetically encoded reporters and animal models rapidly expands, molecular imaging is becoming indispensable for drug discovery and development. Not only do such strategies reduce the time, cost and workload associated with conventional destructive end-point assays, but they also enable spatial and temporal monitoring of in vivo gene expression, signaling pathways, biochemical reactions and targets as they relate to the pharmacokinetics and pharmacodynamics of novel drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available